blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2331709

EP2331709 - GENETIC MARKERS FOR ASSESSING RISK OF DEVELOPING SCHIZOPHRENIA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.04.2014
Database last updated on 31.08.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
SureGene LLC
600 Envoy Circle
Louisville, KY 40299 / US
[2013/21]
Former [2011/24]For all designated states
Suregene Llc
1044 East Chestnut Street, Suite 7
Louisville, KY 40204 / US
Inventor(s)01 / BRENNAN, Mark, David
3920 Charlestown Pike
Jeffersonville, IN 47130 / US
02 / RAMSEY, Timothy, Lynn
2803 Antioch Road
Shelbyville Kentucky 40065 / US
 [2012/08]
Former [2011/24]01 / BRENNAN, Mark, David
1044 E. Chestnut Street 7
Louisville Kentucky 40204 / US
02 / RAMSEY, Timothy, Lynn
2803 Antioch Road
Shelbyville Kentucky 40065 / US
Representative(s)Peterreins, Frank
Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Strasse 8
80807 München / DE
[2013/22]
Former [2011/24]Peterreins, Frank
Fish & Richardson P.C. HighLight Business Towers Mies-van-der-Rohe-Strasse 8
80807 München / DE
Application number, filing date09816956.825.09.2009
[2011/24]
WO2009US58487
Priority number, dateUS20080100176P25.09.2008         Original published format: US 100176 P
[2011/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010036969
Date:01.04.2010
Language:EN
[2010/13]
Type: A2 Application without search report 
No.:EP2331709
Date:15.06.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 01.04.2010 takes the place of the publication of the European patent application.
[2011/24]
Type: B1 Patent specification 
No.:EP2331709
Date:29.05.2013
Language:EN
[2013/22]
Search report(s)International search report - published on:KR07.10.2010
(Supplementary) European search report - dispatched on:EP16.01.2012
ClassificationIPC:C12Q1/68
[2012/51]
CPC:
C12Q1/6883 (EP,US); C12Q2600/106 (EP,US); C12Q2600/156 (EP,US)
Former IPC [2011/24]C12Q1/68, C12N15/11
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/24]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:GENETISCHE MARKER ZUM TESTEN DES RISIKOS DER ENTWICKLUNG EINER SCHIZOPHRENIE[2011/24]
English:GENETIC MARKERS FOR ASSESSING RISK OF DEVELOPING SCHIZOPHRENIA[2011/24]
French:MARQUEURS GÉNÉTIQUES POUR ÉVALUER LE RISQUE D'APPARITION DE LA SCHIZOPHRÉNIE[2011/24]
Entry into regional phase20.04.2011National basic fee paid 
20.04.2011Search fee paid 
20.04.2011Designation fee(s) paid 
20.04.2011Examination fee paid 
Examination procedure20.04.2011Examination requested  [2011/24]
26.07.2012Amendment by applicant (claims and/or description)
05.12.2012Communication of intention to grant the patent
11.04.2013Fee for grant paid
11.04.2013Fee for publishing/printing paid
Divisional application(s)EP13168332.8  / EP2631303
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.12.2012
Opposition(s)03.03.2014No opposition filed within time limit [2014/19]
Fees paidRenewal fee
26.09.2011Renewal fee patent year 03
25.09.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.09.2009
AT29.05.2013
BE29.05.2013
CY29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
IT29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MK29.05.2013
MT29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
TR29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
LU25.09.2013
IS29.09.2013
PT30.09.2013
[2015/34]
Former [2015/33]AT29.05.2013
BE29.05.2013
CY29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
IT29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MK29.05.2013
MT29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
TR29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2015/32]AT29.05.2013
BE29.05.2013
CY29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
IT29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MK29.05.2013
MT29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
TR29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2015/30]AT29.05.2013
BE29.05.2013
CY29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
IT29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2015/24]AT29.05.2013
BE29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
IT29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
SM29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2014/11]AT29.05.2013
BE29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
IT29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2014/10]AT29.05.2013
BE29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2014/09]AT29.05.2013
BE29.05.2013
DK29.05.2013
EE29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2014/06]AT29.05.2013
BE29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2014/02]AT29.05.2013
HR29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/51]AT29.05.2013
HR29.05.2013
LT29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/50]AT29.05.2013
LT29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/49]AT29.05.2013
LT29.05.2013
SI29.05.2013
NO29.08.2013
GR30.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/48]AT29.05.2013
LT29.05.2013
NO29.08.2013
ES09.09.2013
IS29.09.2013
PT30.09.2013
Former [2013/47]LT29.05.2013
NO29.08.2013
PT30.09.2013
Documents cited:Search[A]  - RILEY BRIEN ET AL, "Molecular genetic studies of schizophrenia", EUROPEAN JOURNAL OF HUMAN GENETICS, KARGER, BASEL, CH, (20060601), vol. 14, no. 6, doi:10.1038/SJ.EJHG.5201571, ISSN 1018-4813, pages 669 - 680, XP002519427 [A] 1,3-13 * abstract *

DOI:   http://dx.doi.org/10.1038/SJ.EJHG.5201571
 [A]  - BERTOLINO ET AL, "COMT Val<158>Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia", SCHIZOPHRENIA RESEARCH, ELSEVIER, NETHERLANDS, (20070829), vol. 95, no. 1-3, doi:10.1016/J.SCHRES.2007.06.014, ISSN 0920-9964, pages 253 - 255, XP022217143 [A] 1,3-13 * abstract *

DOI:   http://dx.doi.org/10.1016/j.schres.2007.06.014
International search[A]  - BRAFF ET AL., "Advances in endophenotyping schizophrenia", WORLD PSYCHIATRY, (200802), vol. 7, no. 1, page LL-18, XP008144731
 [A]  - O'DONOVAN ET AL., "Identification of loci associated with schizophrenia by genome-wide association and follow-up", NAT. GENET., (20080730), vol. 40, no. 9, pages 1053 - 1055, XP008144669

DOI:   http://dx.doi.org/10.1038/ng.201
 [A]  - LIU ET AL., "HTF9C gene of 22qll.21 region associates with schizophrenia hav ing deficit-sustained attention", PSYCHIATR. GENET., (200712), vol. 17, no. 6, pages 333 - 338, XP008144671
 [A]  - PINHEIRO ET AL., "AKT1 and neurocognition in schizophrenia", AUST. N. Z. J. PSYCHIATRY., (200702), vol. 41, no. 2, pages 169 - 177, XP008144668
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.